Similar articles

• The difference in tumorigenicity between Epstein-Barr virus (EBV) genome-positive and genome-negative epithelial hybrid cell lines derived from the human nasopharynx.

  Takimoto T, Sato H, Ogura H, Tanaka S, Umeda R. Takimoto T, et al. Laryngoscope. 1988 Dec;98(12):1334-8. doi: 10.1288/00005537-198812000-00010. Laryngoscope. 1988. PMID: 2849005
• Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.

  Takimoto T, Ogura H, Ohno S, Umeda R, Hatano M. Takimoto T, et al. J Natl Cancer Inst. 1984 Sep;73(3):711-5. J Natl Cancer Inst. 1984. PMID: 6088881
• Further studies on growth characteristics of Epstein-Barr virus (EBV) genome-positive and -negative epithelial hybrid cell lines.

  Takimoto T, Tanaka S, Ishikawa S, Masuda K, Umeda R. Takimoto T, et al. Laryngoscope. 1989 Jul;99(7 Pt 1):741-3. doi: 10.1288/00005537-198907000-00015. Laryngoscope. 1989. PMID: 2545984
• Epstein-Barr virus genomes and their biological functions: a review.

  zur Hausen H, Fresen KO, Bornkamm GW. zur Hausen H, et al. IARC Sci Publ (1971). 1978;(24 Pt 1):3-10. IARC Sci Publ (1971). 1978. PMID: 221334 Review. No abstract available.
• Segregation of the EBV-determined nuclear antigen (EBNA) in somatic cell hybrids derived from the fusion of a mouse fibroblast and a human Burkitt lymphoma line.

  Klein G, Wiener F, Zech L, zur Hausen H, Reedman B. Klein G, et al. Int J Cancer. 1974 Jul 15;14(1):54-64. doi: 10.1002/ijc.2910140108. Int J Cancer. 1974. PMID: 4376508 Review. No abstract available.